These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25650573)

  • 1. [Are regional disease management programs for chronic obstructive pulmonary disease useful in everyday clinical practice?].
    Godtfredsen NS
    Ugeskr Laeger; 2015 Feb; 177(6):. PubMed ID: 25650573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic obstructive lung disease management programmes do not benefit the coordination of care pathways].
    Gjersøe P; Morsø L; Jensen MS; Qvist P
    Ugeskr Laeger; 2014 Sep; 176(40):. PubMed ID: 25294515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The COPD national guidelines do have a future].
    Larsson SA; Löfdahl CG
    Lakartidningen; 2007 Jun 13-26; 104(24-25):1891. PubMed ID: 17674667
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polish respiratory society guidelines for chronic obstructive pulmonary disease].
    Sliwiński P; Górecka D; Jassem E; Pierzchała W
    Pneumonol Alergol Pol; 2014; 82(3):227-63. PubMed ID: 24793150
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological treatment optimisation for stable COPD: an endless story? Proposals from the Société de Pneumologie de Langue Française.
    Zysman M; Chabot F; Housset B; Morelot Panzini C; Devillier P; Roche N;
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29025880
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].
    Pierzchała W; Barczyk A; Górecka D; Sliwiński P; Zieliński J;
    Pneumonol Alergol Pol; 2010; 78(5):318-47. PubMed ID: 20703997
    [No Abstract]   [Full Text] [Related]  

  • 7. What is unique about the new Canadian COPD guidelines?
    O'Donnell DE
    Can Respir J; 2004 Apr; 11(3):200-3. PubMed ID: 15124036
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
    Miravitlles M; Roche N; Cardoso J; Halpin D; Aisanov Z; Kankaanranta H; Kobližek V; Śliwiński P; Bjermer L; Tamm M; Blasi F; Vogelmeier CF
    Respir Res; 2018 Jan; 19(1):11. PubMed ID: 29347928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global initiative for chronic obstructive lung disease: Gold standards and the Asia-Pacific perspective.
    Tan WC
    Respirology; 2002 Mar; 7(1):1-2. PubMed ID: 11896894
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 3rd edition].
    Nagai A
    Nihon Rinsho; 2011 Oct; 69(10):1729-34. PubMed ID: 22073564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The COPD national guidelines should be implemented in a better way. The use of non-invasive ventilation is optimal, but spirometry is performed too seldom].
    Berkius J; Walther SM
    Lakartidningen; 2007 Jun 13-26; 104(24-25):1897-901. PubMed ID: 17674668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quality of care in chronic obstructive pulmonary disease].
    Roche N
    Rev Mal Respir; 2006 Jun; 23(3 Suppl):6S44-6S56. PubMed ID: 16820748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What was the impact of the Spanish COPD guidelines (GesEPOC) and how can they be improved?
    Miravitlles M
    Arch Bronconeumol; 2016 Jan; 52(1):1-2. PubMed ID: 26026686
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the GOLD recommendations for chronic obstructive pulmonary disease to broaden their usage in Turkey.
    Gunen H; Kilinc O; Polatli M; Suerdem M; Uzaslan E
    Expert Rev Respir Med; 2016 Jun; 10(6):625-8. PubMed ID: 27015415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the GOLD documents for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Controversies and questions.
    Yusen RD
    Am J Respir Crit Care Med; 2013 Jul; 188(1):4-5. PubMed ID: 23815714
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic obstructive pulmonary disease: clinical review and update on consensus guidelines.
    Bozarth AL; Covey A; Gohar A; Salzman G
    Hosp Pract (1995); 2014 Feb; 42(1):79-91. PubMed ID: 24566600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Japanese Respiratory Society guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease].
    Nihon Kokyuki Gakkai Zasshi; 2004 Apr; Suppl():1-137. PubMed ID: 15156860
    [No Abstract]   [Full Text] [Related]  

  • 18. Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face.
    Bereznicki B; Walters H; Walters J; Peterson G; Bereznicki L
    Intern Med J; 2017 Jul; 47(7):807-813. PubMed ID: 28276136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of patients' perspectives on treatment with noninvasive ventilation in patients with chronic obstructive pulmonary disease-A qualitative study.
    Christensen HM; Huniche L; Titlestad IL
    J Clin Nurs; 2018 Jan; 27(1-2):e61-e69. PubMed ID: 28401600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differences between GesEPOC and GOLD.
    Izquierdo Alonso JL
    Arch Bronconeumol; 2016 Sep; 52(9):453-4. PubMed ID: 27344927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.